Loading clinical trials...
Loading clinical trials...
An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration
Conditions
Interventions
Long term follow up in all patients who received SAR422459 in previous study TDU13583
Locations
2
United States
Oregon Health and Science University Site Number : 840001
Portland, Oregon, United States
Investigational Site Number : 250001
Paris, France
Start Date
December 14, 2012
Primary Completion Date
August 29, 2033
Completion Date
August 29, 2033
Last Updated
June 12, 2025
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions